Translational Addiction Sciences Center
转化成瘾科学中心
基本信息
- 批准号:8842966
- 负责人:
- 金额:$ 128.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsBehaviorBiologyCellsCellular AssayCellular biologyCharacteristicsChemistryChronicCocaineCocaine AbuseCocaine DependenceCommunitiesCorpus striatum structureCuesDiseaseDrug AddictionEquilibriumFunctional Magnetic Resonance ImagingFunctional disorderGap JunctionsGenetic ScreeningGoalsHTR2A geneHealthHomeostasisHomoHumanImpulsive BehaviorImpulsivityIn VitroIndividualKnowledgeLaboratoriesLigandsLinkMentorsMethodologyMissionModalityNatureNeurobiologyNeurophysiology - biologic functionPharmaceutical PreparationsPharmacologyPhenotypePsychopharmacologyReceptor SignalingRelapseResearchRodent ModelRoleScienceSerotoninSignal TransductionThalamic structureaddictioncausal modelcocaine exposurecravingcue reactivitydesignexperiencegenetic variantinsightneurotransmissionpsychologicpublic health relevancereceptorrelating to nervous systemrepairedrestorationsuccess
项目摘要
DESCRIPTION (provided by applicant): Cocaine abuse and dependence continue to extract considerable personal, health and societal tolls in the U.S. and the world. The cycling progressive nature of this disorder stymies efforts to stay abstinent with relapse oft precipitated
by impulsive behavior and craving in the face of exposure to cocaine-associated cues (cue reactivity). Serotonin (5-HT) neurotransmission is a strategic nexus that mechanistically connects these phenotypes. The Translational Addiction Sciences Center (TASC) is comprised of a translational team bridging from molecules to cells to animals to humans with the long-term research goal to definitively reveal the role of 5-HT in addiction neurobiology and to integrate this knowledge into the dominant theoretical constructs of addiction. The central research theme of the TASC is that impulsive action and cue reactivity are mechanistically-linked to disrupted 5-HT signaling through the 5-HT2A receptor (5-HT2AR) and 5-HT2CR localized to prefrontal-striatal-thalamic circuitry. Our premise is that restoration of the 5-HT2AR:5-HT2CR balance will repair corticostriatal deficits and ameliorate relapse. The TASC is led by an experienced, translational team that melds classical and state-of-the-art methodologies, bridging chemistry, cellular biology and pharmacology with human and animal psychopharmacology to address this problem. Project 1 will utilize pharmaco-fMRI, dynamic causal modeling, and human laboratory tasks to demonstrate that 5-HT2R gene variants drive both impulsivity and cue reactivity in cocaine-dependent subjects. Project 2 will employ rodent models to illuminate the 5-HT2AR:5-HT2CR imbalance that drives impulsivity and cue reactivity and to provide the experimental platform to normalize 5-HT2AR:5-HT2CR homeostasis and reduce vulnerability to relapse. Project 3 will design and synthesize bifunctional molecules with targeted actions at 5-HT2R to establish proof-of-concept efficacy against relapse in animal models and to study the unique biology of receptor homo- and heteromers. Synergy will be engendered through the Cellular Biology and Pharmacology Core which will centralize genetic screening in humans, cellular assays In vitro for new ligands, receptor signaling and localization ex vivo and studies of receptor homo- and heteromers. The Administrative Core will centralize, coordinate and facilitate the productive community of the TASC, with particular emphasis on removing barriers to success in translational addiction research, optimizing mentoring experiences, and communicating advances in the TASC and the field to the community at large. The progress of the TASC mission will provides insight Into neural dysfunction in the disordered state of drug dependence and establish that restoration of the 5-HT2AR:5-HT2CR balance with targeted new ligands will repair homeostasis and mitigate deleterious behaviors that promote relapse.
描述(由申请人提供):可卡因滥用和依赖继续在美国和世界上造成相当大的个人、健康和社会损失。这种疾病的循环进行性阻碍了努力保持戒断与复发沉淀
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathryn A. Cunningham其他文献
Proteomics analyses: Peroxisome proliferator-activated receptor gamma agonist for chronic cocaine administration in rodents
- DOI:
10.1016/j.drugalcdep.2015.07.590 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:
- 作者:
Nilesh S. Tannu;Joy Schmitz;Scott D. Lane;C. Green;Kathryn A. Cunningham;Robert Suchting;Juan Herrera;P.A. Narayana - 通讯作者:
P.A. Narayana
Changes in brain white matter integrity after Ppar-gamma agonist treatment for cocaine use disorder
- DOI:
10.1016/j.drugalcdep.2016.08.316 - 发表时间:
2017-02-01 - 期刊:
- 影响因子:
- 作者:
Scott D. Lane;Khader M. Hasan;Benson Mwangi;P.A. Narayana;Jessica Vincent;F. Gerard Moeller;Joel Steinberg;Kelly Dineley;Kathryn A. Cunningham;Joy Schmitz - 通讯作者:
Joy Schmitz
Novel bivalent serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptor ligands demonstrate distinct activities <em>in vitro and in vivo</em>
- DOI:
10.1016/j.drugalcdep.2015.07.1164 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:
- 作者:
Rachel M. Hartley;Scott Gilbertson;Ying-Chu Chen;Noelle C. Anastasio;Robert G. Fox;Sonja J. Stutz;Cheryl Watson;Kathryn A. Cunningham - 通讯作者:
Kathryn A. Cunningham
Effective connectivity of attentional bias in cocaine dependence
- DOI:
10.1016/j.drugalcdep.2016.08.405 - 发表时间:
2017-02-01 - 期刊:
- 影响因子:
- 作者:
F. Gerard Moeller;Liangsuo Ma;Joel Steinberg;James Bjork;Scott D. Lane;P.A. Narayana;Thomas Kosten;Antoine Bechara;Joy Schmitz;Amanda E. Price;Kathryn A. Cunningham - 通讯作者:
Kathryn A. Cunningham
The SoTL Scaffold: Supporting Evidence-Based Teaching Practice in Educational Development
SoTL 支架:支持教育发展中的循证教学实践
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Laura Cruz;Kathryn A. Cunningham;Brian Smentkowski;H. Steiner - 通讯作者:
H. Steiner
Kathryn A. Cunningham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathryn A. Cunningham', 18)}}的其他基金
Novel Addiction Neurocircuits in Cocaine Taking
可卡因吸食中的新型成瘾神经回路
- 批准号:
10595681 - 财政年份:2022
- 资助金额:
$ 128.05万 - 项目类别:
Mechanisms of prenatal opioid exposure on brain and behavior
产前阿片类药物暴露对大脑和行为的机制
- 批准号:
10375927 - 财政年份:2022
- 资助金额:
$ 128.05万 - 项目类别:
Novel Addiction Neurocircuits in Cocaine Taking
可卡因吸食中的新型成瘾神经回路
- 批准号:
10375964 - 财政年份:2022
- 资助金额:
$ 128.05万 - 项目类别:
Mechanisms of prenatal opioid exposure on brain and behavior
产前阿片类药物暴露对大脑和行为的机制
- 批准号:
10657323 - 财政年份:2022
- 资助金额:
$ 128.05万 - 项目类别:
NOP Receptor Antagonist for OUD Pharmacotherapy
用于 OUD 药物治疗的 NOP 受体拮抗剂
- 批准号:
10085851 - 财政年份:2020
- 资助金额:
$ 128.05万 - 项目类别:
Targeting the Ghrelin System for Novel Opioid Use Disorder Therapeutics
针对新型阿片类药物使用障碍治疗的 Ghrelin 系统
- 批准号:
9905262 - 财政年份:2019
- 资助金额:
$ 128.05万 - 项目类别:
Targeting the Ghrelin System for Novel Opioid Use Disorder Therapeutics
针对新型阿片类药物使用障碍治疗的 Ghrelin 系统
- 批准号:
10168769 - 财政年份:2019
- 资助金额:
$ 128.05万 - 项目类别:
Neural and Pharmacological Mechanisms of Abused Drugs
滥用药物的神经和药理学机制
- 批准号:
9404132 - 财政年份:2016
- 资助金额:
$ 128.05万 - 项目类别:
5-HT2 Receptor Allosterism in Cocaine Use Disorder
可卡因使用障碍中的 5-HT2 受体变构
- 批准号:
10445173 - 财政年份:2015
- 资助金额:
$ 128.05万 - 项目类别:
5‐HT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER
5-HT2CR 变构调节剂作为可卡因使用障碍的新型药物治疗
- 批准号:
9271312 - 财政年份:2015
- 资助金额:
$ 128.05万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 128.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists